CiiTECH and Cannassure have announced a major deal to develop and market Provacan THC products for medical cannabis use in Israel. It marks CiiTECH’s long-awaited move into medicinal cannabis. In addition to offering established consumer CBD brands, CiiTECH’s flagship brand Provacan is considered one of the [...]
A one-off event next year will give GPs the opportunity to learn more about the prescribing of medical cannabis in the UK. The UK charity for drug reform, Drug Science will hold a one-off mini conference that gives GPs everything they need to know about medical [...]
The post Sex, pain and stigma: Could CBD lubricant be the answer? appeared first on Cannabis Health News.
Industry-leading CBD company, CBDiablo is hell-bent on making a difference by offering 20 per cent of its profits to suicide prevention There are about a million CBD brands in the UK to choose from – each claiming they offer something different from the next. Founders of [...]
Ryan Gorman, a 26-year-old man, from Dublin, has become the first patient to receive the cannabis-based product, CannEpil, through Ireland’s Medical Cannabis Access Programme (MCAP). The MCAP was introduced four years ago, although this marks the first product to be prescribed under the scheme. It was [...]
Copyright © 2024 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
